Showing 6991-7000 of 23151 results for "".
Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients
https://reachmd.com/programs/diabetes-discourse/why-hybrid-closed-loop-insulin-therapy-should-be-offered-to-pregnant-t1d-patients/16256/A recent study concluded that hybrid closed-loop insulin therapy should be offered to all pregnant patients with type 1 diabetes. Here’s why.A New Era in Primary Biliary Cholangitis Treatment
https://reachmd.com/programs/gi-insights/a-new-era-in-primary-biliary-cholangitis-treatment/49146/Primary biliary cholangitis (PBC) treatment has evolved significantly in recent years, expanding beyond ursodiol to include new targeted therapies and emerging agents in clinical trials. As the therapeutic landscape grows, clinicians are also refining how they assess treatment response using biochemPreventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
https://reachmd.com/programs/project-oncology/preventing-mgussmm-progression-to-multiple-myeloma-with-dietary-interventions/30046/A recent study found that a high-fiber, plant-based diet can delay progression from MGUS and SMM to multiple myeloma. Here are the best foods for patients.No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
https://reachmd.com/programs/acc-action-center/no-effect-on-the-primary-endpoint-with-Ssglt2i-post-mi-but-significant-effect-on-hf-hospitalizations/24287/ACC.24 - Javed Butler shares the findings of the EMPACT-MI trial, in which empagliflozin had no effect on the primary endpoint in patients with acute MI but significant effect on HF hospitalizations.Clinical Conversations Video with Dr Scott Boswell
https://reachmd.com/programs/nemluvio-peer-network/clinical-conversations-video-with-dr-scott-boswell/56420/Join Dr Scott Boswell as he shares how he approaches prurigo nodularis (PN) and atopic dermatitis (AD) in his expansive dermatology practice. From his 3‑step communication framework to compelling patient stories, Dr Boswell emphasizes how prioritizing safety and understanding neuroimmune mechanismsDecoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/decoding-co-mutations-in-hr-her2-metastatic-breast-cancer/39716/Hormone receptor–positive, HER2-negative (HR+, HER2-) metastatic breast cancer often develops resistance through ESR1 and PIK3CA mutations—but what happens when these alterations occur alone or together? Joining Dr. Charles Turck to break down her research from the 2025 San Antonio Breast Cancer SymGiredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
https://reachmd.com/programs/project-oncology/giredestrant-and-everolimus-in-hrher2-breast-cancer-insights-from-evera/36162/As treatment options evolve for patients with HR+/HER2- advanced breast cancer following CDK 4/6 inhibitor therapy, combination strategies are gaining momentum. The evERA Breast Cancer study, which was presented at the 2025 ESMO Congress, explored one dual-targeted approach—giredestrant and everolimGender Bias and Heart Health: Improving Cardiovascular Care for Women
https://reachmd.com/programs/heart-matters/gender-bias-and-heart-health-improving-cardiovascular-care-for-women/37856/Cardiovascular disease is the leading cause of mortality in women, yet it is often underrecognized due to gender bias in healthcare. Hear from Dr. Connie Newman as she explores the impact of bias on cardiovascular risk perception, highlights the importance of lipid and Lp(a) screening, and reviews eThe Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
https://reachmd.com/programs/project-oncology/the-potential-impact-of-rcc-molecular-subtypes-on-treatment-outcomes/26533/Tune in to hear expert insights on recent research investigating if renal cell carcinoma molecular subtypes impact treatment outcomes.Improving Pain Management During Intrauterine Device Insertion
https://reachmd.com/programs/advances-in-womens-health/improving-pain-iud-insertion/48737/Even though pain during intrauterine device (IUD) placement is a major concern for many patients, it's often underestimated in clinical practice. As a result, addressing this issue with empathy and offering patients effective pain management techniques can significantly improve their experience. Joi